Product Information
ISRADIPINE 2.5 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.1589 per EA under NDC 16252053901. Its NADAC has been published 144 times since Nov 28, 2013.
FDA first approved this application on Jan 5, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
16252053901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ISRADIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077317FDA Approved
1/5/2006
TE Code
AB
On Market Since
1/5/2004
Pharmacological Classes
Price Statistics
The NADAC for ISRADIPINE 2.5 MG CAPSULE has been published 144 times since Nov 28, 2013, and over the history we have for it it has risen 23.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1589 per EA |
|---|---|
| All-time high | $1.8070 (Jan 14, 2026) |
| All-time low | $0.9249 (Sep 17, 2014) |
| 52-week high | $1.8070 |
| 52-week low | $1.1589 |
| Median price | $0.9579 |
| Average price | $1.1236 |
| Largest weekly change | +93.8% (Dec 17, 2025) |
| Weeks tracked | 144 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ISRADIPINE 2.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ISRADIPINE 2.5 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.1589 per EA (NDC 16252053901), effective Aug 19, 2026.
How has the price of ISRADIPINE 2.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ISRADIPINE 2.5 MG CAPSULE has risen 23.9%. It has been tracked across 144 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ISRADIPINE 2.5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ISRADIPINE 2.5 MG CAPSULE has ranged from a low of $0.9249 (Sep 17, 2014) to a high of $1.8070 (Jan 14, 2026), with a median of $0.9579 per EA.
Are there cheaper alternatives to ISRADIPINE 2.5 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ISRADIPINE 2.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ISRADIPINE 2.5 MG CAPSULE?
ISRADIPINE 2.5 MG CAPSULE (NDC 16252053901) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.